AGL 38.50 Increased By ▲ 0.93 (2.48%)
AIRLINK 131.71 Decreased By ▼ -0.79 (-0.6%)
BOP 5.59 Decreased By ▼ -0.05 (-0.89%)
CNERGY 3.84 Increased By ▲ 0.07 (1.86%)
DCL 8.71 Decreased By ▼ -0.16 (-1.8%)
DFML 40.80 Decreased By ▼ -0.20 (-0.49%)
DGKC 88.70 Decreased By ▼ -1.46 (-1.62%)
FCCL 35.29 Increased By ▲ 0.21 (0.6%)
FFBL 66.41 Decreased By ▼ -0.09 (-0.14%)
FFL 10.49 Increased By ▲ 0.34 (3.35%)
HUBC 109.70 Increased By ▲ 3.30 (3.1%)
HUMNL 14.66 Increased By ▲ 1.26 (9.4%)
KEL 4.83 Decreased By ▼ -0.03 (-0.62%)
KOSM 7.10 Increased By ▲ 0.25 (3.65%)
MLCF 42.55 Increased By ▲ 0.75 (1.79%)
NBP 59.49 Increased By ▲ 0.91 (1.55%)
OGDC 184.21 Increased By ▲ 2.96 (1.63%)
PAEL 25.59 Decreased By ▼ -0.11 (-0.43%)
PIBTL 5.90 Increased By ▲ 0.07 (1.2%)
PPL 147.80 Decreased By ▼ -0.60 (-0.4%)
PRL 23.58 Increased By ▲ 0.36 (1.55%)
PTC 16.45 Increased By ▲ 1.21 (7.94%)
SEARL 69.22 Increased By ▲ 0.43 (0.63%)
TELE 7.23 Decreased By ▼ -0.01 (-0.14%)
TOMCL 36.09 Increased By ▲ 0.09 (0.25%)
TPLP 7.56 Increased By ▲ 0.16 (2.16%)
TREET 14.19 Decreased By ▼ -0.05 (-0.35%)
TRG 50.90 Increased By ▲ 0.05 (0.1%)
UNITY 26.89 Increased By ▲ 0.49 (1.86%)
WTL 1.23 Increased By ▲ 0.02 (1.65%)
BR100 9,822 Increased By 54.5 (0.56%)
BR30 29,806 Increased By 405.7 (1.38%)
KSE100 92,402 Increased By 464.3 (0.5%)
KSE30 28,842 Increased By 98.2 (0.34%)
Pakistan

Pakistan places order for single-dose Chinese CanSinoBio vaccine

  • Its first tranche of 60,000 doses is expected to be delivered to Pakistan within a week.
  • On February 12, the Drug Regulatory Authority of Pakistan (DRAP) had approved the vaccine for emergency use in Pakistan.
Published March 10, 2021

The National Health Services, Regulation and Coordination (NHS, R&C) has said that Pakistan has placed an order to purchase single-dose of China’s CanSinoBio COVID-19 vaccine.

An official of the NHS told The News, that the first batch of the vaccine is expected to be delivered to Pakistan within a week. "Its first tranche of 60,000 doses is expected to be delivered to Pakistan within a week,” the official said. But, added that no exact date of vaccine delivery could be given at the moment.

The official shared that the vaccine would also be manufactured partially in Pakistan, adding that Pakistani scientists and experts would be trained by the Chinese biotechnology firm for manufacturing the vaccine.

On February 12, the Drug Regulatory Authority of Pakistan (DRAP) had approved the vaccine for emergency use in Pakistan. CanSinoBIO's vaccine was approved for use in the Chinese military last year and has since been given to at least 40,000-50,000 people. It uses a modified common cold virus known as adenovirus type-5 (Ad5) to carry genetic material from the coronavirus protein into the body.

Comments

Comments are closed.